Extension Study of BMN044 in Duchenne Muscular Dystrophy (DMD)
A Multi Center, Multi National, Open Label, Extension Study to Evaluate the Long-term Efficacy and Safety of BMN044 (PRO044) in Subjects With Duchenne Muscular Dystrophy A Multi Center, Multi National, Open Label, Extension Study to Evaluate the Long-term Efficacy and S ...
Duchenne Muscular Dystrophy
Drug: BMN044 IV 6 mg/kg;Drug: BMN044 IV 9 mg/kg;Drug: BMN044 SC 6 mg/kg
A study to assess the effect of BMN044 in subjects with Duchenne muscular dystrophy (Extension study) A study to assess the effect of BMN044in subjects with Duchenne muscular dystrophy (Extension study ...
A multi center, multi national, open label, extension study to evaluate the long-term efficacy and safety of BMN044 (PRO044) in subjects with Duchenne muscular dystrophy A multi center, multi national, open label, extension study to evaluate the long-term efficacy and s ...
A study to assess the effect of BMN044 in subjects with Duchennemuscular dystrophy (Extension study) A study to assess the effect of BMN044in subjects with Duchennemuscular dystrophy (Extension study) ...
A multi center, multi national, open label, extension study to evaluate the long-term efficacy and safety of BMN044 (PRO044) in subjects with Duchenne muscular dystrophy - NA A multi center, multi national, open label, extension study to evaluate the long-term efficacy and s ...